摘要
目的探讨Graves病患者血清β2M测定的意义。方法用放免法测定61例Graves病患者治疗前后血清T3、T4与β2M含量,并与健康对照组56例对比。结果治疗前组血清T3、T4与β2M均显著高于健康对照组(P<0001),治疗后T3、T4及与β2M也同步降至正常,与治疗前组比P<0001。结论测定血清β2M是了解Graves病免疫学状况、观察疗效、判断预后、估计复发的一个简便而有价值的检验方法。
Objective To investigate the clinical significance of Sβ2M in Graves diseases(GD).Method The contents of Sβ2Μ、T3 and T4 was measured by RIA method in 61 cases of GD before and after antigoiter therapy,and compared with these of 56 cases of healthy controls.Results T3 and T4 and Sβ2Μ were synchronously increased in the pretherapeutic group and also synchronously decreased to normal ranges in posttherapeutic group.Conclusion Sβ2Μ measurement is a simple、conveiniant and valuable lab method for evaluating the immunological condition、therapeutic effectiveness and prognosis in GD.
出处
《泰山医学院学报》
CAS
1998年第3期231-232,共2页
Journal of Taishan Medical College
关键词
甲状腺肿
甲亢
Β2微球蛋白
放射免疫分析
graves diseases
hyperthyroidism
β2microglobulin
radioimmunoassay